FR2717478B1 - Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. - Google Patents

Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.

Info

Publication number
FR2717478B1
FR2717478B1 FR9409478A FR9409478A FR2717478B1 FR 2717478 B1 FR2717478 B1 FR 2717478B1 FR 9409478 A FR9409478 A FR 9409478A FR 9409478 A FR9409478 A FR 9409478A FR 2717478 B1 FR2717478 B1 FR 2717478B1
Authority
FR
France
Prior art keywords
receptor
drugs
compounds
human
diagnostic tools
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9409478A
Other languages
English (en)
Other versions
FR2717478A1 (fr
Inventor
Daniel Bichon
Xavier Emonds-Alt
Patrick Gueule
Vincenzo Proietto
Didier Van Broeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9403193A external-priority patent/FR2717477B1/fr
Application filed by Sanofi SA filed Critical Sanofi SA
Priority to FR9409478A priority Critical patent/FR2717478B1/fr
Priority to FR9500571A priority patent/FR2719311B1/fr
Priority to NZ270727A priority patent/NZ270727A/en
Priority to PL95307723A priority patent/PL185075B1/pl
Priority to DK95400590T priority patent/DK0673928T3/da
Priority to IL11302695A priority patent/IL113026A/xx
Priority to RU95103737/04A priority patent/RU2143425C1/ru
Priority to AU14909/95A priority patent/AU693845B2/en
Priority to FI951265A priority patent/FI116621B/fi
Priority to HU9500806A priority patent/HUT72065A/hu
Priority to AT95400590T priority patent/ATE204863T1/de
Priority to EP95400590A priority patent/EP0673928B1/fr
Priority to PT95400590T priority patent/PT673928E/pt
Priority to NO951044A priority patent/NO302944B1/no
Priority to DE69522355T priority patent/DE69522355T2/de
Priority to ES95400590T priority patent/ES2164746T3/es
Priority to CN95103542A priority patent/CN1056605C/zh
Priority to SI9530543T priority patent/SI0673928T1/xx
Priority to KR1019950005722A priority patent/KR100238343B1/ko
Priority to TW084102614A priority patent/TW380138B/zh
Priority to JP7061419A priority patent/JP2922816B2/ja
Priority to CA002145000A priority patent/CA2145000C/fr
Publication of FR2717478A1 publication Critical patent/FR2717478A1/fr
Priority to US08/608,718 priority patent/US5942523A/en
Priority to US08/607,976 priority patent/US5741910A/en
Publication of FR2717478B1 publication Critical patent/FR2717478B1/fr
Application granted granted Critical
Priority to NO975089A priority patent/NO303823B1/no
Priority to HK98104342A priority patent/HK1005137A1/xx
Priority to US09/306,825 priority patent/US6124316A/en
Priority to CY0200032A priority patent/CY2278B1/xx
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9409478A 1994-03-18 1994-07-29 Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. Expired - Fee Related FR2717478B1 (fr)

Priority Applications (28)

Application Number Priority Date Filing Date Title
FR9409478A FR2717478B1 (fr) 1994-03-18 1994-07-29 Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR9500571A FR2719311B1 (fr) 1994-03-18 1995-01-19 Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
NZ270727A NZ270727A (en) 1994-03-18 1995-03-16 Piperidine derivatives and pharmaceutical compositions
PL95307723A PL185075B1 (pl) 1994-03-18 1995-03-16 Nowe pochodne N-(3,4-dichlorofenylopropylo)piperydyny będące selektywnymi antagonistami ludzkiego receptora NK3, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te związki
DE69522355T DE69522355T2 (de) 1994-03-18 1995-03-17 Neue N-(3,4-Dichlorphenyl-propyl)-piperidin-Derivate als selektive humane NK3-Rezeptorantagonisten
IL11302695A IL113026A (en) 1994-03-18 1995-03-17 Selective antagonists of the human nk3 receptor their preparation pharmaceutical compositions containing them and their use for the preparation of phamraceutical compositions
RU95103737/04A RU2143425C1 (ru) 1994-03-18 1995-03-17 Производные пиперидина, их соли, способы их получения, фармацевтическая композиция на их основе и промежуточные вещества
AU14909/95A AU693845B2 (en) 1994-03-18 1995-03-17 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
FI951265A FI116621B (fi) 1994-03-18 1995-03-17 Ihmisen NK3-reseptoreille selektiivisiä antagonistiyhdisteitä, valmistusmenetelmiä, niitä sisältäviä farmaseuttisia koostumuksia ja niiden käyttö lääkeaineina ja diagnostisina aineina
HU9500806A HUT72065A (en) 1994-03-18 1995-03-17 Selective antagonistic compounds of human nk3 receptor and their use in pharmaceutical and diagnostical compositions
AT95400590T ATE204863T1 (de) 1994-03-18 1995-03-17 Neue n-(3,4-dichlorphenyl-propyl)-piperidin- derivate als selektive humane nk3- rezeptorantagonisten
EP95400590A EP0673928B1 (fr) 1994-03-18 1995-03-17 Nouveaux dérivés de la N-(3,4-dichlorophényl-propyl)-pipéridine comme antagonistes sélectifs du récepteur NK3 humain
PT95400590T PT673928E (pt) 1994-03-18 1995-03-17 Novos derivaos da n-(3,4-diclorofenil-propil)-piperidina como antagonistas selectivos do receptor nk3 humano
NO951044A NO302944B1 (no) 1994-03-18 1995-03-17 Selektive antagonist-forbindelser for menneske-NK3-reseptor, farmasöytiske preparater inneholdende dem, og deres anvendelse til fremstilling av medikamenter
DK95400590T DK0673928T3 (da) 1994-03-18 1995-03-17 Nye N-(3,4-dichlorphenyl-propyl)-piperidin-derivater som selektive humane NK3-receptorantagonister
ES95400590T ES2164746T3 (es) 1994-03-18 1995-03-17 Nuevos derivados de la n-(3,4-diclorofenil-propil)-piperidina como antagonistas selectivos del receptor nk3 humano.
CN95103542A CN1056605C (zh) 1994-03-18 1995-03-17 作为人速激肽ⅲ受体的选择性拮抗剂的化合物及其用途
SI9530543T SI0673928T1 (en) 1994-03-18 1995-03-17 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selective human NK3-receptor antagonists
TW084102614A TW380138B (en) 1994-03-18 1995-03-18 Piperidine derivatives which are selective antagonists of the human NK3 receptor and their use as medicinal products
KR1019950005722A KR100238343B1 (ko) 1994-03-18 1995-03-18 인간 nk3 수용기의 선택적 길항제인 화합물, 및 의약품 및 진단기구로서의 그의 용도
JP7061419A JP2922816B2 (ja) 1994-03-18 1995-03-20 ヒトｎｋ３受容体の選択的拮抗剤である化合物並びに医薬品及び診断ツールとしてのこれらの使用
CA002145000A CA2145000C (fr) 1994-03-18 1995-03-20 Antagonistes selectifs du recepteur humain nk3 et leur utilisation comme produits medicinaux et diagnostiques
US08/608,718 US5942523A (en) 1994-03-18 1996-02-29 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
US08/607,976 US5741910A (en) 1994-03-18 1996-02-29 Compounds which are selective antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
NO975089A NO303823B1 (no) 1994-03-18 1997-11-04 Piperidinderivater
HK98104342A HK1005137A1 (en) 1994-03-18 1998-05-19 Novel n-(3,4-dichlorophenylpropyl) piperidine derivatives as selective human nk3-receptor antagonists
US09/306,825 US6124316A (en) 1994-03-18 1999-05-07 Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools
CY0200032A CY2278B1 (en) 1994-03-18 2002-05-15 Novel N-(3,4-dichlorophenyl-propyl)-piperidine derivatives as selectibe human nk3-receptor antagonists

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9403193A FR2717477B1 (fr) 1994-03-18 1994-03-18 Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR9409478A FR2717478B1 (fr) 1994-03-18 1994-07-29 Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.

Publications (2)

Publication Number Publication Date
FR2717478A1 FR2717478A1 (fr) 1995-09-22
FR2717478B1 true FR2717478B1 (fr) 1996-06-21

Family

ID=26231016

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9409478A Expired - Fee Related FR2717478B1 (fr) 1994-03-18 1994-07-29 Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.

Country Status (1)

Country Link
FR (1) FR2717478B1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) * 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.

Also Published As

Publication number Publication date
FR2717478A1 (fr) 1995-09-22

Similar Documents

Publication Publication Date Title
PT804419E (pt) Derivados de quinolina como antagonistas do receptor de taquiquinina nk3
DK0738150T3 (da) Bicykliske fibrinogene antagonister
DE69734833D1 (de) Vitronektin rezeptor antagonisten
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
NO980007D0 (no) Fremgangsmåte for ekstrudering av slanger for medisinsk bruk
FI963154A0 (fi) Foerfarande foer upploesning av zinkslig under atmosfaeriska foer haollanden
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
NO980008L (no) Fremgangsmåte for ekstrudering av slanger for medisinsk bruk
TR199501389A2 (tr) Adesyon reseptörü antagonistleri (karsitlari).
FR2717478B1 (fr) Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2717477B1 (fr) Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
DE29702094U1 (de) Einrichtung für den Sanitärbereich
BR9408265A (pt) Antagonistas de receptor de c5a não tendo substancialmente nenhuma atividade de antagonista
NO971525D0 (no) Medisinsk utstyr
NO953050D0 (no) Anvendelse av neurotensin-antagonister for fremstilling av diuretiske medikamenter
DE29704490U1 (de) Monitorkonstruktion
ES1030229Y (es) Dispositivo cortador del caliz y del pedunculo de fresas y fresones.
DE69722503D1 (de) Katalysatorüberwachung
ZA978233B (en) The use of protein as anti-retroviral agents.
DE29620244U1 (de) Diagnostikgerät
NO972771D0 (no) Ny reseptor
DE29613549U1 (de) Binokulares indirektes Ophthalmoskop
DE29605287U1 (de) Baugerüstkonsole
DK1011716T3 (da) Neuromedin B-receptor-antagonister
HUP9904642A3 (en) Use of lh-rh antagonists as diagnostic agent

Legal Events

Date Code Title Description
CA Change of address
TP Transmission of property
CD Change of name or company name
ST Notification of lapse

Effective date: 20100331